Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
10 - 31 Aug 2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
24 February 1987
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 434 (Acute Dermal Toxicity - Fixed Dose Procedure)
Version / remarks:
Proposal for a New Draft Guideline, May 2004
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Slovak National Accreditation Service, Karloveska 63, 840 00 Bratislava 4, Slovak Republic
Test type:
fixed dose procedure
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
4-(octadecylamino)-4-oxoisocrotonic acid
EC Number:
221-361-2
EC Name:
4-(octadecylamino)-4-oxoisocrotonic acid
Cas Number:
3077-27-8
Molecular formula:
C22H41NO3
IUPAC Name:
4-(octadecylamino)-4-oxoisocrotonic acid
Test material form:
solid

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Dobrá Voda, Slovak Republic
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 195 - 200 g (f), 220 - 230 g (m)
- Housing: 3 animals per cage
- Bedding: Lignocel S3/4, Lufa - ITL GmbH, Germany
- Diet: ssniff (Spezialdiäten GmbH, Germany), provided at recommended doses each day approximately at the same time
- Water: tap water, ad libitum
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23.18 ± 0.45
- Humidity (%): 55.40 ± 3
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12 / 12

IN-LIFE DATES: From: To: 15 - 31 August 2017

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
olive oil
Details on dermal exposure:
TEST SITE
- Area of exposure: clipped and shaved dorsal area of trunk
- % coverage: approx. 10% of total body surface area
- Type of wrap if used: semi-occlusive dressing with non-irritating tape

REMOVAL OF TEST SUBSTANCE
- Washing: residual test item was removed with lukewarm water
- Time after start of exposure: 24 h

VEHICLE
- Justification for choice of vehicle: Olive oil is a standard vehicle according to test guideline
- Lot/batch no.: L63417
- Expiry date: 06/2018
- Manufacturer: Oleificio Luca, Italy
- Storage temperature (°C): 20 ± 5

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Available information indicated that the test item is likely to be non-toxic with regard to acute toxicity. Hence, a limit dose of 2000 mg/kg body weight was used as a starting dose.
Duration of exposure:
24 h
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
not required
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: immediately after dosing, 0.5, 1, 2 and 4 h after administration, daily for the next 14 days
- Frequency of weighing: immediately prior to dosing and weekly thereafter
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross necropsy

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
All 5/5 females and 5/5 males at the limit dose of 2000 mg/kg body weight survived.
Clinical signs:
Animals lived through observation period without signs of intoxication. Neither change of health nor negative reactions were observed.
Body weight:
The body weight of all females increased during the study, stagnation of body weight in two females between the first and second week was noticed.
Gross pathology:
All animals (5 females and 5 males) were necropsied. During necropsy, no macroscopic changes were noticed.

Any other information on results incl. tables

  Table 1: Body Weights and Body Weight Differences

 

Sex

Dose

ID

Body Weight (g)

Body Weight Difference (g)

Initial

Week 1

Week 2

Week 1 - Initial

Week 2 - Initial

Week 2 - Week 1

 

 

 

 

2000 mg/kg

1

195

205

210

10

15

5

2

200

200

225

0

25

25

3

200

200

215

0

15

15

4

200

220

220

20

20

0

5

195

210

210

15

15

0

 

 

 

 

2000 mg/kg

6

230

250

275

20

45

25

7

230

250

270

20

40

20

8

230

235

250

5

20

15

9

230

245

260

15

30

15

10

220

245

260

25

40

15

Applicant's summary and conclusion

Interpretation of results:
other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008.
Conclusions:
The LD50 of the test item has been determined to be greater than 2000 mg/kg body weight after single dermal administration to male and female Wistar rats.